Weijie Li

<p class="MsoNormal"><span lang="EN-US" style="font-size: 11.0pt; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-ansi-language: EN-US;">Dr. Weijie Li is a pediatric hematopathologist, board-certified in anatomic pathology, clinical pathology, and hematopathology. He has served as the Director of Hematopathology and Flow Cytometry at Children's Mercy Hospital in Kansas City, United States, for over 10 years. Through many years of practice, he has developed clinical expertise in diagnosing pediatric leukemias, lymphomas, and other hematolymphoid diseases, as well as in monitoring therapeutic responses, especially measurable residual disease (MRD) in acute leukemias. His research focuses on diagnostic and prognostic biomarkers of leukemia and lymphoma, MRD detection, and the deregulation of signaling pathways in pediatric leukemia and lymphoma. </span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size: 11.0pt; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-ansi-language: EN-US;">Dr. Li is a Professor of Pathology at the University of Missouri-Kansas City School of Medicine and is actively involved in teaching medical students, pathology residents, and hematopathology and hematology-oncology fellows. Moreover, Dr. Li serves as a reviewer for numerous peer-reviewed journals and has published extensively in hematopathology, flow cytometry, and hematology-oncology.</span></p>